![Sukhi Jagpal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sukhi Jagpal
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Sukhi Jagpal
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
45
| Extinct | Miscellaneous Commercial Services | 45 |
Extinct | Biotechnology | 42 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sukhi Jagpal
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal Sales & Marketing | |
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Davis | College/University | Director/Board Member Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Viventia Biotech, Inc.
![]() Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Operating Officer | |
University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Simon Fraser University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Alberta | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
MedImmune Vaccines, Inc.
![]() MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member President General Counsel | |
CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Chief Operating Officer Public Communications Contact | |
The University of Texas at Austin | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
Mati Therapeutics, Inc.
![]() Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Biotechnology | Founder Director of Finance/CFO Founder | |
ImStar Therapeutics, Inc.
![]() ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Founder Director/Board Member Founder | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
University of Michigan | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Axys Pharmaceuticals, Inc.
![]() Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Renovis, Inc.
![]() Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genome British Columbia
![]() Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
LaTrobe University | College/University | Masters Business Admin Masters Business Admin | |
HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer General Counsel | |
Haas School of Business | College/University | Masters Business Admin Masters Business Admin | |
RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Corporate Officer/Principal Human Resources Officer | |
University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Masters Business Admin Corporate Officer/Principal | |
VERA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Secretary Founder | |
RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 38 |
Kanada | 11 |
Vereinigtes Königreich | 3 |
Australien | 2 |
Sektoral
Health Technology | 27 |
Consumer Services | 17 |
Commercial Services | 6 |
Finance | 2 |
Process Industries | 2 |
Operativ
Director/Board Member | 476 |
Corporate Officer/Principal | 195 |
Independent Dir/Board Member | 163 |
Chairman | 72 |
Undergraduate Degree | 66 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
James Topper | 52 |
Alan C. Mendelson | 45 |
Peter Thompson | 39 |
Donald Parfet | 31 |
Philip B. Livingston | 31 |
Albert Cha | 30 |
Kathryn Falberg | 30 |
John Thomas | 30 |
Paul Hastings | 25 |
Bruce Carter | 25 |
Joseph Turner | 22 |
John Kozarich | 21 |
Mohammad Azab | 21 |
Gaurav Aggarwal | 21 |
Geoffrey F. Cox | 20 |
- Börse
- Insiders
- Sukhi Jagpal
- Unternehmensverbindungen